(3S)​-​3-​{[(Benzyloxy)​carbonyl]​amino}​-​4-​tert-​butoxy-​4-​oxobutanoic acid Dicyclohexylamine Salt

• Catalog number
  B286995
• Price
  Please ask
• Size
  500 mg

• Chemical available in other sizes
  Please inquire size and price
• Stock availability
  Please Inquire
• Cas number
  17335-87-4
• Chemical s molecular weight
  504.66
• Chemical s main applications
  (3S)​-​3-​{[(benzyloxy)​carbonyl]​amino}​-​4-​tert-​butoxy-​4-​oxobutanoic acid is used in preparation of disubstituted indazoles as potent antagonists of the integrin αvβ3.
• Chemical s category
  Amines, Aromatics, Chiral Reagents, Miscellaneous Reagents
• Other name
  N-​[(Phenylmethoxy)​carbonyl]​-​L-aspartic Acid 1-​(1,​1-​Dimethylethyl) Ester N-Cyclohexylcyclohexan​amine; N-carboxy-L-aspartic acid N-benzyl 1-tert-butyl ester compd. with dicyclohexylamine; N-carboxy-aspartic acid N-benzyl 1-tert-butyl ester compd. with dicyclohexylamine;
• Chemical s formula
  C28H44N2O6
• Physical properties
  White Solid
• Melting temperature
  111-113°C
• Boiling temperature
  No Data Available
• Chemical s soluble in
  DMSO, Methanol
• Stability conditions
  No Data Available
• Storage
  -20°C Freezer
• Chemical s specifications

• Gene target
  ​-​3   ​{[   Benzyloxy   ​carbonyl]​amino}​-​4   ​tert   ​butoxy   ​oxobutanoic   acid   Dicyclohexylamine   Salt  
• Short name
  (3S)​-​3-​{[(Benzyloxy)​carbonyl]​amino}​-​4-​tert-​butoxy-​4-​oxobutanoic acid Dicyclohexylamine Salt
• Alternative name
  (3S)​-​3-​{[(Benzyloxy)​carbonyl]​amino}​-​4-​telomerase reverse transcriptase-​butoxy-​4-​oxobutanoic acid Dicyclohexylamine Salt
• Alternative to gene target
  telomerase reverse transcriptase, CMM9 and DKCA2 and DKCB4 and EST2 and hEST2 and hTRT and PFBMFT1 and TCS1 and TP2 and TRT, TERT and IDBG-10998 and ENSG00000164362 and 7015, telomeric RNA binding, nuclei, Tert and IDBG-165912 and ENSMUSG00000021611 and 21752, BT.60929 and IDBG-632169 and ENSBTAG00000012567 and 518884

MeSH Data

• Name
  Cloning, Molecular
• Concept
  Scope note: The insertion of recombinant DNA molecules from prokaryotic and/or eukaryotic sources into a replicating vehicle, such as a plasmid or virus vector, and the introduction of the resultant hybrid molecules into recipient cells without altering the viability of those cells.
• Tree numbers
  • E05.393.220
• Qualifiers
  drug effects, methods, radiation effects

Similar products